The Pretreatment Neutrophil/Lymphocyte Ratio Is Associated with All-Cause Mortality in Black and White Patients with Non-metastatic Breast Cancer

Overview of attention for article published in Frontiers in oncology, March 2016

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 16 publications that cite this research output.

16

The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.

Association of neutrophil-to-lymphocyte ratio with clinical, pathological, radiological, laboratory features and disease outcomes of invasive breast cancer patients: A retrospective observational cohort study

Article in Medicine (May 2023)

An Integrative Clinical Model for the Prediction of Pathological Complete Response in Patients with Operable Stage II and Stage III Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy

Article in Cancers (August 2022)

Relationship Between the Neutrophil to Lymphocyte Ratio, Stromal Tumor-infiltrating Lymphocytes, and the Prognosis and Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer

Article in Clinical Breast Cancer (April 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.